BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9221772)

  • 1. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.
    Cragg SJ; Greenfield SA
    J Neurosci; 1997 Aug; 17(15):5738-46. PubMed ID: 9221772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Cragg SJ; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):853-62. PubMed ID: 9065854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences.
    Cragg SJ; Hawkey CR; Greenfield SA
    J Neurochem; 1997 Dec; 69(6):2378-86. PubMed ID: 9375669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
    Chen BT; Rice ME
    J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
    Chen BT; Moran KA; Avshalumov MV; Rice ME
    J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area.
    Chen BT; Rice ME
    J Neurochem; 2002 Apr; 81(1):158-69. PubMed ID: 12067228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of somatodendritic dopamine release by endogenous H(2)O(2): susceptibility in substantia nigra but resistance in VTA.
    Chen BT; Avshalumov MV; Rice ME
    J Neurophysiol; 2002 Feb; 87(2):1155-8. PubMed ID: 11826083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area.
    Chen BT; Patel JC; Moran KA; Rice ME
    Front Syst Neurosci; 2011; 5():39. PubMed ID: 21716634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens.
    Iravani MM; Muscat R; Kruk ZL
    Neuroscience; 1996 Feb; 70(4):1025-37. PubMed ID: 8848165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Richards CD; Nedergaard S; Hounsgaard J; Nicholson C; Greenfield SA
    Exp Brain Res; 1994; 100(3):395-406. PubMed ID: 7813678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing.
    Courtney NA; Mamaligas AA; Ford CP
    J Neurosci; 2012 Sep; 32(39):13520-8. PubMed ID: 23015441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons.
    Castelli MP; Spiga S; Perra A; Madeddu C; Mulas G; Ennas MG; Gessa GL
    Neuroscience; 2016 Sep; 332():130-9. PubMed ID: 27365174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.
    Patel JC; Witkovsky P; Avshalumov MV; Rice ME
    J Neurosci; 2009 May; 29(20):6568-79. PubMed ID: 19458227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-dependent somatodendritic dopamine release in the substantia nigra autoinhibits the releasing neuron.
    Hikima T; Lee CR; Witkovsky P; Chesler J; Ichtchenko K; Rice ME
    Cell Rep; 2021 Apr; 35(1):108951. PubMed ID: 33826884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatodendritic dopamine release: recent mechanistic insights.
    Rice ME; Patel JC
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback control of mesolimbic somatodendritic dopamine release in rat brain.
    Rahman S; McBride WJ
    J Neurochem; 2000 Feb; 74(2):684-92. PubMed ID: 10646520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptotagmins 1 and 7 Play Complementary Roles in Somatodendritic Dopamine Release.
    Hikima T; Witkovsky P; Khatri L; Chao MV; Rice ME
    J Neurosci; 2022 May; 42(19):3919-3930. PubMed ID: 35361702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.